Reply

Affiliations

¹ Division of Digestive and Liver Diseases, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern, Dallas, Texas.
² Harold C. Simmons Comprehensive Cancer Center, Department of Radiation Oncology, Center for Human Nutrition, UT Southwestern, Dallas, Texas.
³ Division of Digestive and Liver Diseases, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, Department of Radiation Oncology, UT Southwestern, Dallas, Texas.
⁴ Division of Digestive and Liver Diseases, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern, Dallas Texas.

Comment

Nicole E Rich et al. Clin Gastroenterol Hepatol. 2022 Dec.

. 2022 Dec;20(12):2923-2925.

doi: 10.1016/j.cgh.2022.01.049. Epub 2022 Feb 4.

¹ Division of Digestive and Liver Diseases, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern, Dallas, Texas.
² Harold C. Simmons Comprehensive Cancer Center, Department of Radiation Oncology, Center for Human Nutrition, UT Southwestern, Dallas, Texas.
³ Division of Digestive and Liver Diseases, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, Department of Radiation Oncology, UT Southwestern, Dallas, Texas.
⁴ Division of Digestive and Liver Diseases, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern, Dallas Texas.

No abstract available

Comment on

Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?
Huo TI, Ho SY, Hsu CY. Huo TI, et al. Clin Gastroenterol Hepatol. 2022 Dec;20(12):2923. doi: 10.1016/j.cgh.2021.12.041. Epub 2021 Dec 28. Clin Gastroenterol Hepatol. 2022. PMID: 34971807 No abstract available.